Abiopharma

ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19

Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference

INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference

Inspire Medical Systems, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference

Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health

CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India

TriSalus Life Sciences Launches TriNav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™

Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access

InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for its Alzheimer’s Disease Candidate INM-901